UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolomic Profile in HFpEF vs HFrEF Patients

Journal of cardiac failure, 2020-12, Vol.26 (12), p.1050-1059

2020

Volltextzugriff (PDF)

Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization

Scientific reports, 2018-05, Vol.8 (1), p.7458-10, Article 7458

2018

Volltextzugriff (PDF)

VEGF-D GENETIC VARIANTS ARE SIGNIFICANTLY ASSOCIATED TO PLASMA VEGF-D LEVELS AND PREDICT MORTALITY IN PATIENTS WITH CARDIOVASCULAR DISEASES

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.955

2022

Volltextzugriff (PDF)

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction

PloS one, 2018-04, Vol.13 (4), p.e0196601-e0196601

2018

Volltextzugriff (PDF)

Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age : Establishment of reference values

Clinical chemistry (Baltimore, Md.), 2001-10, Vol.47 (10), p.1776-1781

2001

Volltextzugriff (PDF)

Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke

Journal of Alzheimer's disease, 2000-10, Vol.2 (3-4), p.199-206

2000

Volltextzugriff (PDF)

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Proteome science, 2004-11, Vol.2 (1), p.7-7

2004

Volltextzugriff (PDF)

Development of a highly sensitive liquid chromatography - mass spectrometry method to quantify plasma leukotriene E 4 and demonstrate pharmacological suppression of endogenous 5-LO pathway activity in man

Prostaglandins & other lipid mediators, 2020-10, p.106463

2020

Volltextzugriff (PDF)

Development of a highly sensitive liquid chromatography–mass spectrometry method to quantify plasma leukotriene E4 and demonstrate pharmacological suppression of endogenous 5-LO pathway activity in man

Prostaglandins & other lipid mediators, 2020-10, Vol.150, p.106463-106463, Article 106463

2020

Volltextzugriff (PDF)

Glycoproteomics of cerebrospinal fluid in neurodegenerative disease

International journal of mass spectrometry, 2004-05, Vol.234 (1), p.145-152

2004

Volltextzugriff (PDF)

Patient-Centric Quantitative Microsampling for Accurate Determination of Urine Albumin to Creatinine Ratio (UACR) in a Clinical Setting

The journal of applied laboratory medicine, 2024-03, Vol.9 (2), p.329-341

2024

Volltextzugriff (PDF)

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment

Scientific reports, 2018-12, Vol.8 (1), p.17545-14, Article 17545

2018

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Mild Cognitive Impairment

Acta neurologica Scandinavica. Supplementum, 2003, Vol.107 (179), p.47-51

2003

Volltextzugriff (PDF)

Abstract 11521: Circulating Thymosin Beta-4 is Elevated in Women With Heart Failure

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A11521-A11521

2016

Volltextzugriff (PDF)

Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Archives of neurology (Chicago), 2001-03, Vol.58 (3)

2001

Volltextzugriff (PDF)

Proteome studies of CSF in AD patients: Dementias and cognitive disorders: new insights and approaches

Mechanisms of ageing and development, 2006, Vol.127 (2), p.133-137

2006

Volltextzugriff (PDF)

Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry

Proteomics (Weinheim), 2001-03, Vol.1 (3), p.444-452

2001

Volltextzugriff (PDF)

Contribución de la apolipoproteína CIII a la aterogenicidad de las dislipidemias

Clínica e investigación en arteriosclerosis, 2012-09, Vol.24 (5), p.252-260

2012

Volltextzugriff (PDF)

Proteomics for drug target discovery

Chemometrics and intelligent laboratory systems, 2004-09, Vol.73 (1), p.47-53

2004

Volltextzugriff (PDF)

Membrane Protein Profiling of Human Islets of Langerhans Using Several Extraction Methods

Clinical proteomics, 2010-12, Vol.6 (4), p.195-207

2010

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Longitudinal studies on CSF biochemistry in MCI

Acta neurologica Scandinavica, 2003-02, Vol.107, p.47-51

2003

Volltextzugriff (PDF)

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

Acta neurologica Scandinavica, 2003-02, Vol.107 (s179), p.47-51

2003

Volltextzugriff (PDF)

Identification of Protein Vaccine Candidates from Helicobacter p ylori Using a Preparative Two-Dimensional Electrophoretic Procedure and Mass Spectrometry

Analytical chemistry (Washington), 2000-05, Vol.72 (9), p.2148-2153

2000

Volltextzugriff (PDF)

Human Cerebrospinal Fluid

Biomedical Applications of Proteomics, 2004, p.341-353

2004

Volltextzugriff (PDF)

CSF Markers for Early Alzheimer's Disease

Alzheimer's Disease, 2001, p.275-283

2001

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(28)
Buchkapitel
(3)

Sprache

Englisch
(30)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolomic Profile in HFpEF vs HFrEF Patients

Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization

VEGF-D GENETIC VARIANTS ARE SIGNIFICANTLY ASSOCIATED TO PLASMA VEGF-D LEVELS AND PREDICT MORTALITY IN PATIENTS WITH CARDIOVASCULAR DISEASES

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction

Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age : Establishment of reference values

Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Development of a highly sensitive liquid chromatography - mass spectrometry method to quantify plasma leukotriene E 4 and demonstrate pharmacological suppression of endogenous 5-LO pathway activity in man

Development of a highly sensitive liquid chromatography–mass spectrometry method to quantify plasma leukotriene E4 and demonstrate pharmacological suppression of endogenous 5-LO pathway activity in man

Glycoproteomics of cerebrospinal fluid in neurodegenerative disease

Patient-Centric Quantitative Microsampling for Accurate Determination of Urine Albumin to Creatinine Ratio (UACR) in a Clinical Setting

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Mild Cognitive Impairment

Abstract 11521: Circulating Thymosin Beta-4 is Elevated in Women With Heart Failure

Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Proteome studies of CSF in AD patients: Dementias and cognitive disorders: new insights and approaches

Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry

Contribución de la apolipoproteína CIII a la aterogenicidad de las dislipidemias

Proteomics for drug target discovery

Membrane Protein Profiling of Human Islets of Langerhans Using Several Extraction Methods

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment: Longitudinal studies on CSF biochemistry in MCI

Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

Identification of Protein Vaccine Candidates from Helicobacter p ylori Using a Preparative Two-Dimensional Electrophoretic Procedure and Mass Spectrometry

Human Cerebrospinal Fluid

CSF Markers for Early Alzheimer's Disease

Aktive Filter

Suchergebnisse filtern